Clinical Trials Browser

Withdrawn × INDUSTRY × plerixafor × Clear all

NCT00396968 2014-02-11

AMD3100 With Busulfan, Fludarabine and Thymoglobulin for Allogeneic Stem Cell Transplant for AML and MDS

Phase 1/2 Withdrawn

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute